0000884905-18-000082.txt : 20181102
0000884905-18-000082.hdr.sgml : 20181102
20181102110043
ACCESSION NUMBER: 0000884905-18-000082
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181031
FILED AS OF DATE: 20181102
DATE AS OF CHANGE: 20181102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Strauss David P
CENTRAL INDEX KEY: 0001705851
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11037
FILM NUMBER: 181155902
MAIL ADDRESS:
STREET 1: 10 RIVERVIEW DRIVE
CITY: DANBURY
STATE: CT
ZIP: 06810
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PRAXAIR INC
CENTRAL INDEX KEY: 0000884905
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL INORGANIC CHEMICALS [2810]
IRS NUMBER: 061249050
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 RIVERVIEW DRIVE
CITY: DANBURY
STATE: CT
ZIP: 06810
BUSINESS PHONE: 2038372000
MAIL ADDRESS:
STREET 1: 10 RIVERVIEW DRIVE
CITY: DANBURY
STATE: CT
ZIP: 06810
FORMER COMPANY:
FORMER CONFORMED NAME: UNION CARBIDE INDUSTRIAL GASES INC
DATE OF NAME CHANGE: 19600201
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2018-10-31
1
0000884905
PRAXAIR INC
PX
0001705851
Strauss David P
C/O PRAXAIR, INC.
10 RIVERVIEW DRIVE
DANBURY
CT
06810
0
1
0
0
Vice President Human Resources
Common Stock
2018-10-31
4
D
0
1625.6827
0
D
0
I
401(k)
Common Stock
2018-10-31
4
D
0
8778.943
0
D
0
D
Restricted Stock Units
0
2018-10-31
4
D
0
2720
0
D
Common Stock
2720
0
D
Restricted Stock Units
0
2018-10-31
4
D
0
570
0
D
Common Stock
570
0
D
Restricted Stock Units
0
2018-10-31
4
D
0
2168
0
D
Common Stock
2168
0
D
Restricted Stock Units
0
2018-10-31
4
D
0
585
0
D
Common Stock
585
0
D
Restricted Stock Units
0
2018-10-31
4
D
0
1490
0
D
Common Stock
1490
0
D
Stock Option (right to buy)
60.92
2018-10-31
4
D
0
5220
D
2019-02-24
Common Stock
5220
0
D
Stock Option (right to buy)
76.16
2018-10-31
4
D
0
3070
D
2020-02-23
Common Stock
3070
0
D
Stock Option (right to buy)
97.84
2018-10-31
4
D
0
3630
D
2021-02-22
Common Stock
3630
0
D
Stock Option (right to buy)
109.68
2018-10-31
4
D
0
4610
D
2022-02-28
Common Stock
4610
0
D
Stock Option (right to buy)
110.58
2018-10-31
4
D
0
4255
D
2023-02-26
Common stock
4255
0
D
Stock Option (right to buy)
128.80
2018-10-31
4
D
0
4305
D
2024-02-25
Common Stock
4305
0
D
Stock Option (right to buy)
128.38
2018-10-31
4
D
0
5150
D
2025-02-24
Common Stock
5150
0
D
Stock Option (right to buy)
102.22
2018-10-31
4
D
0
7955
D
2026-02-23
Common Stock
7955
0
D
Stock Option (right to buy)
118.71
2018-10-31
4
D
0
19815
D
2027-02-28
Common Stock
19815
0
D
Stock Option (right to buy)
154.00
2018-10-31
4
D
0
22635
D
2028-02-27
Common Stock
22635
0
D
Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.
Restricted Stock Units ("RSUs") that were previously awarded by Praxair, Inc. that will vest 100% on February 27, 2021. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis.
Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.
Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.
This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
This options vests over three years in three consecutive equal annual installments beginning on February 23, 2017. In accordance with the Buiness Combination Agreement , each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Anthony M. Pepper, Attorney-in-Fact
2018-11-02